Journal of Immune Based Therapies, Vaccines and Antimicrobials

Show Articles
Journal Properties
  • Number of Articles
    19
  • Abbreviation
    JIBTVA
  • ISSN
    2168-1546
  • e-ISSN
    2168-1554
  • Publisher
    Scientific Research Publishing, Inc.
  • Indian UGC
  • DOAJ (latest)
Description
The Journal of Immune Based Therapies, Vaccines and Antimicrobials is a peer-reviewed, open-access journal dedicated to advancing the understanding and application of immune-based therapies, vaccines, and antimicrobial agents. This specialized journal serves as a platform for disseminating cutting-edge research in immunology, vaccinology, and infectious diseases. This journal covers a wide range of topics, including the development and evaluation of novel vaccines, immunotherapeutic strategies for cancer and autoimmune diseases, and the discovery and application of new antimicrobial agents. It provides insights into clinical microbiology, epidemiology, and translational research, targeting researchers, clinicians, and industry professionals involved in developing and implementing innovative healthcare solutions. Indexed in major databases, it ensures broad visibility and accessibility of published work. With a commitment to open access, the journal ensures that the latest findings are readily available to the global scientific community, accelerating the pace of scientific discovery and innovation. Authors are encouraged to submit high-quality research articles, reviews, and perspectives, contributing to the collective effort to combat diseases and improve patient outcomes. Join us in shaping the future of immune-based interventions.